ETC
Exchange Traded Concepts Portfolio holdings
AUM
$7.83B
1-Year Return
24.45%
This Quarter Return
+5.89%
1 Year Return
+24.45%
3 Year Return
+83.69%
5 Year Return
+131.49%
10 Year Return
–
AUM
$2.67B
AUM Growth
+$518M
(+24%)
Cap. Flow
+$443M
Cap. Flow
% of AUM
16.57%
Top 10 Holdings %
Top 10 Hldgs %
37.97%
Holding
1,213
New
223
Increased
556
Reduced
256
Closed
177
Top Buys
| 1 |
Cameco
CCJ
|
$20M |
| 2 |
Vanguard Mid-Cap Value ETF
VOE
|
$12.4M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
$12.1M |
| 4 |
iShares US Real Estate ETF
IYR
|
$11.9M |
| 5 |
Bally's
BALY
|
$11.2M |
Top Sells
| 1 |
Biogen
BIIB
|
$9.91M |
| 2 |
MetLife
MET
|
$8.66M |
| 3 |
US Bancorp
USB
|
$6.02M |
| 4 |
Microsoft
MSFT
|
$4.88M |
| 5 |
Adobe
ADBE
|
$4.71M |
Sector Composition
| 1 | Healthcare | 10.33% |
| 2 | Consumer Discretionary | 9.01% |
| 3 | Technology | 6.11% |
| 4 | Consumer Staples | 4.77% |
| 5 | Financials | 4.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
DexCom
DXCM
$31.6B
| $3.08M | 0.12% |
34,244
+8,712
| +34% | +$783K |
|
127
EPR Properties
EPR
$4.05B
| $3.08M | 0.12% |
66,010
+13,888
| +27% | +$647K |
|
128
NeoGenomics
NEO
$1.03B
| $3.03M | 0.11% |
62,816
+29,497
| +89% | +$1.42M |
|
129
Bio-Rad Laboratories Class A
BIO
$8B
| $3.01M | 0.11% |
5,276
+1,701
| +48% | +$971K |
|
130
Exact Sciences
EXAS
$10.2B
| $3M | 0.11% |
22,796
+10,230
| +81% | +$1.35M |
|
131
CME Group
CME
$94.4B
| $3M | 0.11% |
14,668
+12,227
| +501% | +$2.5M |
|
132
Editas Medicine
EDIT
$248M
| $2.98M | 0.11% |
70,935
+20,521
| +41% | +$862K |
|
133
Aon
AON
$79.9B
| $2.96M | 0.11% |
+12,858
| New | +$2.96M |
|
134
Revvity
RVTY
$10.1B
| $2.95M | 0.11% |
22,982
+9,153
| +66% | +$1.17M |
|
135
Axogen
AXGN
$735M
| $2.95M | 0.11% |
145,469
+40,600
| +39% | +$823K |
|
|
SRC
136
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $2.95M | 0.11% |
69,325
+18,363
| +36% | +$780K |
|
137
Essential Properties Realty Trust
EPRT
$6.1B
| $2.94M | 0.11% |
128,554
+37,149
| +41% | +$848K |
|
138
CareDx
CDNA
$736M
| $2.93M | 0.11% |
43,016
+17,842
| +71% | +$1.21M |
|
139
Boston Scientific
BSX
$159B
| $2.91M | 0.11% |
75,391
+23,450
| +45% | +$906K |
|
140
Global Net Lease
GNL
$1.77B
| $2.9M | 0.11% |
160,520
+53,241
| +50% | +$962K |
|
141
Glaukos
GKOS
$5.39B
| $2.89M | 0.11% |
34,434
+9,676
| +39% | +$812K |
|
142
IQVIA
IQV
$31.9B
| $2.87M | 0.11% |
14,840
+5,111
| +53% | +$987K |
|
143
Innovative Industrial Properties
IIPR
$1.61B
| $2.87M | 0.11% |
15,901
+3,683
| +30% | +$664K |
|
144
Fulgent Genetics
FLGT
$672M
| $2.84M | 0.11% |
29,422
-7,310
| -20% | -$706K |
|
145
iRhythm Technologies
IRTC
$5.82B
| $2.84M | 0.11% |
20,432
+10,585
| +107% | +$1.47M |
|
146
Health Catalyst
HCAT
$238M
| $2.81M | 0.11% |
60,083
+15,791
| +36% | +$739K |
|
147
Estee Lauder
EL
$32.1B
| $2.79M | 0.1% |
9,593
+8,843
| +1,179% | +$2.57M |
|
148
Invesco DB US Dollar Index Bullish Fund
UUP
$174M
| $2.78M | 0.1% |
110,767
-7,384
| -6% | -$185K |
|
|
ILPT
149
Industrial Logistics Properties Trust
ILPT
$407M
| $2.77M | 0.1% |
119,622
+41,334
| +53% | +$956K |
|
150
Agilent Technologies
A
$36.5B
| $2.75M | 0.1% |
21,645
+8,237
| +61% | +$1.05M |
|